SinoMab BioScience Limited (HKG:3681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.125
-0.025 (-2.17%)
Sep 18, 2026, 3:54 PM HKT

SinoMab BioScience Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
151.78322.7161.9203.66345.71562.98
Short-Term Investments
-5.833.892.8746.226.55
Trading Asset Securities
52.6648.7144.9830.9930.48-
Cash & Short-Term Investments
204.44377.25110.77237.53422.39589.53
Cash Growth
42.86%240.57%-53.36%-43.77%-28.35%-35.66%
Prepaid Expenses
10.711.838.563.2212.236.16
Other Current Assets
21.8210.816629.4412.47-
Total Current Assets
236.96389.9185.34270.18447.09595.69
Property, Plant & Equipment
432.31501550.72536.77485.82356.21
Long-Term Investments
-----26.93
Other Intangible Assets
0.170.350.941.842.61.92
Other Long-Term Assets
15.1516.8616.1138.9972.8460.91
Total Assets
684.58908.11753.1847.791,0081,042

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accrued Expenses
-2.283.075.9311.367.85
Current Portion of Long-Term Debt
114.37134.72112.6466.5930.425
Current Portion of Leases
4.297.5812.944.6615.387.39
Current Unearned Revenue
---0.30.31.55
Other Current Liabilities
56.2359.4674.8595.17129.9376.57
Total Current Liabilities
174.89204.04203.5172.65187.3998.36
Long-Term Debt
145.84192.09306.65324.81238.36193.78
Long-Term Leases
2.344.1150.0454.7573.0269.29
Total Liabilities
323.06400.23560.19552.2498.77361.43

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,2182,2181,7901,7251,7251,679
Retained Earnings
--1,780-1,675-1,490-1,247-962.96
Comprehensive Income & Other
-1,85770.0378.1960.631.48-35.94
Shareholders' Equity
361.52507.88192.91295.58509.58680.23
Total Liabilities & Equity
684.58908.11753.1847.791,0081,042

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
266.83338.49482.27450.81357.18275.46
Net Cash (Debt)
-62.438.76-371.5-213.2865.2314.07
Net Cash Growth
-----79.24%-61.62%
Net Cash Per Share
-0.050.03-0.35-0.210.070.32
Filing Date Shares Outstanding
1,3871,3871,0921,0351,0351,006
Total Common Shares Outstanding
1,3871,3871,0921,0351,0351,006
Working Capital
62.08185.86-18.1697.54259.7497.32
Book Value Per Share
0.260.370.180.290.490.68
Tangible Book Value
361.35507.52191.98293.74506.98678.31
Tangible Book Value Per Share
0.260.370.180.280.490.67
Machinery
-58.6667.266.458.6147.02
Construction In Progress
-462.89453.07419.14336.16197.47
Leasehold Improvements
-28.3528.4828.3733.4229.81